Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Vir Biotechnology Inc (NASDAQ: VIR) closed at $10.11 up 0.60% from its previous closing price of $10.05. In other words, the price has increased by $0.60 from its previous closing price. On the day, 1.09 million shares were traded. VIR stock price reached its highest trading level at $10.28 during the session, while it also had its lowest trading level at $10.02.
Ratios:
For a deeper understanding of Vir Biotechnology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 08 ’25 when SATO VICKI L sold 10,960 shares for $12.52 per share. The transaction valued at 137,219 led to the insider holds 1,312,391 shares of the business.
VICKI LEE SATO bought 43,840 shares of VIR for $345,898 on Jan 08 ’25. On Dec 02 ’24, another insider, de Verneuil Vanina, who serves as the EVP and General Counsel of the company, sold 76 shares for $8.22 each. As a result, the insider received 625 and left with 56,973 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 1392349184 and an Enterprise Value of 590689408. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.71 while its Price-to-Book (P/B) ratio in mrq is 1.11. Its current Enterprise Value per Revenue stands at 7.513 whereas that against EBITDA is -1.106.
Stock Price History:
The Beta on a monthly basis for VIR is 0.59, which has changed by 0.053125024 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $6.56. The 50-Day Moving Average of the stock is 20.71%, while the 200-Day Moving Average is calculated to be 15.44%.
Shares Statistics:
For the past three months, VIR has traded an average of 2.13M shares per day and 6077810 over the past ten days. A total of 136.71M shares are outstanding, with a floating share count of 87.71M. Insiders hold about 36.31% of the company’s shares, while institutions hold 49.09% stake in the company. Shares short for VIR as of 1735603200 were 6553893 with a Short Ratio of 3.07, compared to 1732838400 on 6163469. Therefore, it implies a Short% of Shares Outstanding of 6553893 and a Short% of Float of 7.7199996.
